semaglutide fda weight loss FDA-Approved Oral Pill Minnesota doctor says FDA weight-loss

Any observed associations are more likely related to secondary factors such as hydration status or pre-existing patient risk factors

Ozempic is only licensed as a type 2 diabetes treatment, although its been gaining attention online as a weight loss treatment because it contains semaglutide (the same active ingredient as Wegovy)

It follows a more fixed, program-style approach, while Found offers a more flexible model with personalized coaching that adjusts to your needs

In both studies, participants randomly received either 10 or 15 milligrams of Zepbound or placebo once weekly for 52 weeks

doi: 10.3389/fimmu.2026.1755316 Received 27 November 2025 Revised 11 July 2026 Accepted 22 July 2026 Published 03 August 2026 Volume 17 - 2026 Edited by Manuel Muro, Virgen de la Arrixaca University Hospital, Spain Reviewed by Paola Pontrelli, University of Bari Aldo Moro, Italy Benjamin Spector, University of Wisconsin-Madison, United States Updates Copyright 2026 Zhang, Zheng, Zheng, He, Chen, Luo, Wang and Cai